Association Between CD147 Expression, RAS Mutational Status, and Local Recurrence in Resected Locally Advanced Rectal Cancer

ABSTRACT Aim About 5% to 10% of rectal cancer (RC) patients experience local disease recurrence after chemoradiotherapy (CRT) and surgery. Identifying patients at high risk of local recurrence (LR) could lead to the personalized management of the patients. Multiple clinicopathological parameters are...

詳細記述

書誌詳細

出版年:	Cancer Medicine
主要な著者:	Anaëlle Isnard, Laure‐Amandine Cramier, Rémi Vergara, Mehdi Boubaddi, Donatien Fouche, Benjamin Fernandez, Nathalie Senant, Quentin Denost, Éric Rullier, Pierre Dubus, Sandrine Dabernat, Charles Dupin, Véronique Vendrely, Anne Rullier, Samuel Amintas
フォーマット:	論文
言語:	英語
出版事項:	Wiley 2025-08-01
主題:	BRAF CD147 EMMPRIN gender KRAS local recurrence
オンライン･アクセス:	https://doi.org/10.1002/cam4.71087